Reply: Does adjunctive hemoadsorption with CytoSorb® affect survival of COVID-19 patients on ECMO? A critical statement.

Putzu, Alessandro; Schorer, Raoul

Putzu, Alessandro; Schorer, Raoul.

Putzu A; Division of Anesthesiology, Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland. Electronic address: Alessandro.Putzu@hcuge.ch.
Schorer R; Division of Anesthesiology, Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland. Electronic address: Raoul.Schorer@hcuge.ch.

J Crit Care ; 66: 189-190, 2021 12.

Article in English | MEDLINE | ID: covidwho-1330948

Subject(s)

COVID-19; Extracorporeal Membrane Oxygenation; Hemoperfusion; Cytokines; Humans; SARS-CoV-2

Keywords

ARDS; COVID-19; CytoSorb®; Cytokine; Hemoadsorption; Hemoperfusion; Mortality; Randomized trial; Safety

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Extracorporeal Membrane Oxygenation / Hemoperfusion / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Crit Care Journal subject: Critical Care Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google